Onward Medical · ISIN: NL0015000HT4

ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference...

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

This news feed is a compilation of company-relevant news from the most popular and widest-reaching newswire services. The feed is updated several times. For market-related publications, we recommend the X-Billboard, the Daily News Digest or our Premium Information Service.
Most recent update: 13.01.2025 | 06:30
13 January 2025 06:30AM
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ONWARD Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference...
© Globe Newswire
09 January 2025 06:30AM
ONWARD Medical Announces First Commercial Sales of ARC-EX System
ONWARD Medical Announces First Commercial Sales of ARC-EX System...
© Globe Newswire
19 December 2024 04:58PM
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury
ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System...
© Globe Newswire
26 November 2024 06:30AM
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights
ONWARD Medical Provides Q3 2024 Update and Year-to-Date Highlights...
© Globe Newswire
12 November 2024 06:30AM
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights
ONWARD Medical Schedules Webcast to Provide Q3 2024 Update and Year-to-Date Highlights...
© Globe Newswire
28 October 2024 04:45PM
ONWARD® Medical Publishes Closing of Bookbuild Offering
ONWARD® Medical Publishes Closing of Bookbuild Offering...
© Globe Newswire
22 October 2024 03:45PM
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40 Million including EUR 22.5 Million Cornerstone Investment from Ottobock SE & Co. KGaA
ONWARD® Medical Launches Capital Increase for Indicative Amount of c. EUR 40M including EUR 22.5M Cornerstone Investment from Ottobock SE & Co. KGaA...
© Globe Newswire
19 September 2024 05:30AM
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury...
© Globe Newswire
10 September 2024 05:30AM
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update...
© Globe Newswire
03 September 2024 05:30AM
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System...
© Globe Newswire
27 August 2024 04:53PM
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update...
© Globe Newswire
05 August 2024 09:47PM
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights...
© Globe Newswire
09 July 2024 05:18PM
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy...
© Globe Newswire
28 June 2024 09:53PM
ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)...
© Globe Newswire
13 June 2024 09:36PM
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders
ONWARD® Medical Announces Results of Annual General Meeting of Shareholders: shareholders approve all proposed resolutions...
© Globe Newswire
23 May 2024 05:30AM
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights
ONWARD® Medical Reports Q1 2024 Update and Year-to-Date Highlights...
© Globe Newswire
21 May 2024 04:25PM
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication
ONWARD® Medical to Host Webcast to Share Details from its Up-LIFT Trial and Yesterday’s Nature Medicine Publication...
© Globe Newswire
20 May 2024 03:35PM
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
Nature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy...
© Globe Newswire
14 May 2024 10:21PM
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
ONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update...
© Globe Newswire
02 May 2024 05:00AM
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions...
© Globe Newswire

The information service offers company-relevant news from leading newswire services in a compact form for a quick overview. When the detailed view is called up, further information can be accessed if required. The navigation elements in previewer mode allow you to quickly switch to the most frequently visited tool sections. From there, you can access further areas that can be used for your own research and analysis. Tip: The information platform now includes more than 50 mini-apps developed in-house.

AI First: Feel free to test the AI integration that will quickly put you on a par with financial journalists and research houses

Further information

The information presented in this section is secondary publications. The content corresponds to the source information. You can find information on the author of the news item in the detailed information of a publication. News relating to listed companies may have been created due to regulatory publication obligations, due to regular public relations work for PR or marketing reasons or by third parties against the background of investor information.

The combination of information and graphic elements contributes significantly to visual orientation and navigation through complex issues. This makes it easier to grasp, contextualize and process key content. Images, logos and other or comparable graphic and textual elements used on the information portal are used for visual navigation, are part of the original message or have illustrative purposes. All rights to these elements are held by the respective owners of the trademark or image rights. They are used without intent to infringe copyright or intellectual property rights. Image material provided via the distribution networks is treated as part of the original message and processed accordingly.

If you believe that copyright or intellectual property rights have been infringed by the presentation, please contact us immediately to clarify your concerns.